Basic & Clinical Medicine ›› 2025, Vol. 45 ›› Issue (2): 263-267.doi: 10.16352/j.issn.1001-6325.2025.02.0263
• Mini Reviews • Previous Articles Next Articles
WANG Tingting, QIN Haidong*
Received:
2024-05-07
Revised:
2024-07-15
Online:
2025-02-05
Published:
2025-01-17
Contact:
*qhd1234567890@njmu.edu.cn
CLC Number:
WANG Tingting, QIN Haidong. Mechanisms and therapeutic strategies of sepsis-associated cytokine storm[J]. Basic & Clinical Medicine, 2025, 45(2): 263-267.
[1] | 石丹丹, 蒋素芳, 王茜,等. IL-6反式信号传导通路抑制剂sgp130Fc抑制脓毒症小鼠炎性反应及调节免疫细胞[J]. 基础医学与临床, 2022, 42: 1895-1899. |
[2] | Jarczak D, Kluge S, Nierhaus A. Sepsis-pathophysiology and therapeutic concepts[J]. Front Med (Lausanne), 2021, 8: 628302.doi: 10.3389/fmed.2021.628302. |
[3] | Mangalmurti N, Hunter CA. Cytokine storms: understanding COVID-19[J]. Immunity, 2020, 53: 19-25. |
[4] | Jarczak D, Nierhaus A. Cytokine storm-definition, causes, and implications[J]. Int J Mol Sci, 2022, 23.doi: 10.3390/ijms231911740. |
[5] | Cui Z, Wang L, Li H, et al. Study on immune status alterations in patients with sepsis[J]. Int Immuno-pharmacol, 2023, 118: 110048.doi: 10.1016/j.intimp.2023.110048. |
[6] | Karki R, Kanneganti TD. Innate immunity, cytokine storm, and inflammatory cell death in COVID-19[J]. J Transl Med, 2022, 20: 542.doi: 10.1186/s12967-022-03767-z. |
[7] | Orning P, Lien E. Multiple roles of caspase-8 in cell death, inflammation, and innate immunity[J]. J Leukoc Biol, 2021, 109: 121-141. |
[8] | Malireddi RKS, Gurung P, Kesavardhana S, et al. Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease[J]. J Exp Med, 2020, 217.doi: 10.1084/jem.20191644. |
[9] | Karki R, Sharma BR, Tuladhar S, et al. Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes[J]. Cell, 2021, 184: 149-168 e117. |
[10] | 孙晓丽, 张进进, 宋凤英,等. Tim-3/galectin-9调控脂多糖诱导的人淋巴细胞中Th1/Th2细胞平衡[J]. 基础医学与临床, 2023, 43: 1542-1548. |
[11] | Li Z, Feng Y, Zhang S, et al. A multifunctional nanoparticle mitigating cytokine storm by scavenging multiple inflammatory mediators of sepsis[J]. ACS Nano, 2023, 17: 8551-8563. |
[12] | Tang H, Qin S, Li Z, et al. Early immune system alterations in patients with septic shock[J]. Front Immunol, 2023, 14: 1126874.doi: 10.3389/fimmu.2023.1126874. |
[13] | Darden DB, Bacher R, Brusko MA, et al. Single-cell RNA-seq of human myeloid-derived suppressor cells in late sepsis reveals multiple subsets with jnique transcriptional responses: a pilot study[J]. Shock, 2021, 55: 587-595. |
[14] | Darden DB, Kelly LS, Fenner BP, et al. Dysregulated immunity and immunotherapy after sepsis[J]. J Clin Med, 2021, 10.doi: 10.3390/jcm10081742. |
[15] | Galvan-Roman JM, Rodriguez-Garcia SC, Roy-Vallejo E, et al. IL-6 serum levels predict severity and response to Tocilizumab in COVID-19: an observational study[J]. J Allergy Clin Immunol, 2021, 147: 72-80 e78. |
[16] | Bronte V, Ugel S, Tinazzi E, et al. Baricitinib restrains the immune dysregulation in patients with severe COVID-19[J]. J Clin Invest, 2020, 130: 6409-6416. |
[17] | Hwang SJ, Wang JH, Lee J S, et al. Ginseng sprouts attenuate mortality and systemic inflammation by modulating TLR4/NF-kappaB signaling in an LPS-induced mouse model of sepsis[J]. Int J Mol Sci, 2023, 24.doi: 10.3390/ijms24021583. |
[18] | Ono Y, Maejima Y, Saito M, et al. TAK-242, a specific inhibitor of Toll-like receptor 4 signalling, prevents endotoxemia-induced skeletal muscle wasting in mice[J]. Sci Rep, 2020, 10: 694.doi: 10.1038/s41598-020-57714-3. |
[19] | Yang M, Fang JT, Zhang NS, et al. Caspase-1-inhibitor AC-YVAD-CMK inhibits pyroptosis and ameliorates acute kidney injury in a model of sepsis[J]. Biomed Res Int, 2021, 2021: 6636621.doi: 10.1155/2021/6636621. |
[20] | Lesnik P, Janc J, Mierzchala-Pasierb M, et al. Interleukin-7 and interleukin-15 as prognostic biomarkers in sepsis and septic shock: correlation with inflammatory markers and mortality[J]. Cytokine, 2023, 169: 156277.doi: 10.1016/j.cyto.2023.156277. |
[21] | Joshi I, Carney WP, Rock EP. Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis[J]. Front Immunol, 2023, 14: 1130214.doi: 10.3389/fimmu.2023.1130214. |
[22] | Chang C, Hu L, Sun S, et al. Regulatory role of the TLR4/JNK signaling pathway in sepsis-induced myo-cardial dysfunction[J]. Mol Med Rep, 2021, 23.doi: 10.3892/mmr.2021.11973. |
[23] | Zhang T, Yu-Jing L, Ma T. Role of regulation of PD-1 and PD-L1 expression in sepsis[J]. Front Immunol, 2023, 14: 1029438.doi: 10.3389/fimmu.2023.1029438. |
[24] | Nakamori Y, Park EJ, Shimaoka M. Immune deregulation in sepsis and septic shock: reversing immune paralysis by targeting PD-1/PD-L1 pathway[J]. Front Immunol, 2020, 11: 624279.doi: 10.3389/fimmu.2020.624279. |
[25] | Yim D, Lee DE, So Y, et al. Sustainable nanosheet antioxidants for sepsis therapy via scavenging intracellular reactive oxygen and nitrogen species[J]. ACS Nano, 2020, 14: 10324-10336. |
[1] | XU Weijie, CHEN Jiacai, ZHAO Li, YU Zhongying, ZHU Xianzhong, LI Jinyu. Correlation of peripheral blood miR-452 and miR-221 levelswith urinary sepsis after percutaneous nephrolithotomy with holmium laser [J]. Basic & Clinical Medicine, 2025, 45(3): 298-302. |
[2] | XING Yurun, CHEN Suying, TU Jinheng, HE Bosheng. Effects of intestinal ischemia-reperfusion injury on distal organ function [J]. Basic & Clinical Medicine, 2025, 45(3): 395-398. |
[3] | LI Jinping, LIU Hanqing, YANG Quanhui. Change of cell cycle in rat spleen after severe abdominal infection [J]. Basic & Clinical Medicine, 2024, 44(6): 828-832. |
[4] | SUN Xiaoli, ZHANG Jinjin, SONG Fengying, HUANG Yongli, CHEN Lili, XING Yanchao. Tim-3/galectin-9 regulates Th1/Th2 cell balance in lipopolysaccharide-induced human lymphocytes [J]. Basic & Clinical Medicine, 2023, 43(10): 1542-1548. |
[5] | WANG Yingchen, SUN Liqun. Progress on application of dipeptidyl peptidase Ⅲ in the treatment of sepsis [J]. Basic & Clinical Medicine, 2023, 43(1): 196-199. |
[6] | XUE Jin-fang, SONG Hai-fei, CHEN Guo-bing. Research progress of programmed cell death in the occurrence and development of sepsis [J]. Basic & Clinical Medicine, 2022, 42(8): 1284-1287. |
[7] | KUANG Zhong-shen, CONG Zhu-kai, WU Chang-yi, YANG Ning, ZONG Ya-nan, GUO Xiang-yang. Research progress on the role and mechanism of visfatin in sepsis-related organ injury [J]. Basic & Clinical Medicine, 2022, 42(8): 1279-1283. |
[8] | LIN Bai-bai, QIAN Feng-hua, QIAN Yi-ming, ZHAO Lei, SUN Qi, CHU Meng-yao, SHEN Meng-wen. Research progress of sepsis complicated with capillary leakage syndrome [J]. Basic & Clinical Medicine, 2022, 42(7): 1144-1147. |
[9] | WEN Yan, LIN Jin-can, HUANG Ying-hong, XIAO Wen-biao, ZHANG Min-wei, LIN Jian-dong. Changes of BMP-2 and BMP-4 in early phase of sepsis [J]. Basic & Clinical Medicine, 2022, 42(4): 628-632. |
[10] | SHI Dan-dan, JIANG Su-fang, WANG Qian, ZHAO Peng-bo, LIU Ya. IL-6 trans-signaling inhibitor sgp130Fc suppresses inflammation and regulates immune cells in mice with sepsis [J]. Basic & Clinical Medicine, 2022, 42(12): 1895-1899. |
[11] | LI Jia-jin, LIU Jun, HE Song-yu, CHEN Hao-yun. Down-regulation of miR-27a alleviates lung injury in septic rat models [J]. Basic & Clinical Medicine, 2022, 42(11): 1704-1708. |
[12] | SI Xiao-yan, WANG Han-ping, ZHANG Li, WANG Meng-zhao, ZHANG Xiao-tong. Cytokine release syndrome caused by immune checkpoint inhibitor: a case report [J]. Basic & Clinical Medicine, 2022, 42(11): 1764-1766. |
[13] | WANG Yu-long, TENG Wen-bin, SHAN Yue, YAO Liu-xu, HE Rui, LI Yu-hong, ZHU Sheng-mei. Effects of HIF-1α agonist or inhibitor on intestinal mucosal permeability in rats with sepsis [J]. Basic & Clinical Medicine, 2021, 41(11): 1618-1623. |
[14] | SHAO Rui-fei, YANG Yan, ZHENG Zhi-rong, ZHAO Shi-min, CHEN Guo-bing. Function of gut microbiota and “gut-lung” axis in sepsis [J]. Basic & Clinical Medicine, 2020, 40(8): 1109-1112. |
[15] | HE Rui, ZHU Ye-ke, TENG Wen-bin, SHAN Yue, YI Sheng-hua, ZHU Sheng-mei, LI Yu-hong. Glycerol may reduce intestinal mucosal barrier damage in sepsis mice through aquaporin 3 [J]. Basic & Clinical Medicine, 2020, 40(5): 655-661. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||
Full text 19
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Abstract 72
|
|
|||||||||||||||||||||||||||||||||||||||||||||